Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $2.99 Million - $3.66 Million
86,800 New
86,800 $3.66 Million
Q2 2022

Aug 15, 2022

SELL
$63.06 - $84.75 $486,444 - $653,761
-7,714 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $571,993 - $766,463
7,714 New
7,714 $625,000
Q4 2021

Feb 14, 2022

SELL
$86.01 - $102.89 $434,694 - $520,006
-5,054 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $3.45 Million - $3.92 Million
-40,678 Reduced 88.95%
5,054 $442,000
Q2 2021

Aug 13, 2021

BUY
$76.44 - $89.57 $3.5 Million - $4.1 Million
45,732 New
45,732 $4.09 Million
Q1 2021

May 17, 2021

SELL
$67.36 - $80.76 $13.9 Million - $16.6 Million
-206,031 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$53.08 - $69.86 $7.16 Million - $9.42 Million
134,829 Added 189.36%
206,031 $14 Million
Q3 2020

Nov 16, 2020

BUY
$51.29 - $65.09 $3.65 Million - $4.63 Million
71,202 New
71,202 $3.79 Million
Q2 2020

Aug 13, 2020

SELL
$34.32 - $62.43 $1.54 Million - $2.81 Million
-44,969 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$32.64 - $73.63 $3.83 Million - $8.63 Million
-117,251 Reduced 72.28%
44,969 $1.77 Million
Q4 2019

Feb 14, 2020

SELL
$48.0 - $59.55 $908,496 - $1.13 Million
-18,927 Reduced 10.45%
162,220 $9.65 Million
Q3 2019

Nov 14, 2019

SELL
$46.64 - $55.39 $2.24 Million - $2.66 Million
-47,938 Reduced 20.93%
181,147 $9.64 Million
Q2 2019

Aug 14, 2019

BUY
$40.81 - $52.42 $2.12 Million - $2.73 Million
52,036 Added 29.39%
229,085 $11.7 Million
Q1 2019

May 14, 2019

SELL
$36.91 - $55.7 $7.62 Million - $11.5 Million
-206,567 Reduced 53.85%
177,049 $9.17 Million
Q4 2018

Feb 14, 2019

BUY
$36.49 - $51.72 $12.7 Million - $18 Million
348,260 Added 985.01%
383,616 $15.1 Million
Q3 2018

Nov 14, 2018

BUY
$46.5 - $53.55 $1.64 Million - $1.89 Million
35,356 New
35,356 $1.82 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.